Medicines360 Statement on Title X Rule Change

As the leading nonprofit pharmaceutical company addressing women’s most pressing health needs, Medicines360 has continuously and strongly opposed the new rule restricting Title X-funded clinics from providing patients with medically accurate and comprehensive health information.

Our concerns about this rule’s impact on the availability, accessibility and affordability of quality women’s health and family planning services are already being realized, as the change is driving highly qualified providers out of the Title X program. The effect is real: an immediate harm to millions of women who will no longer have access through a healthcare professional to information about all 18 FDA-approved contraceptive methods, nor the exams, screenings and referrals essential for good health.

Political agendas should not stand in the way of healthcare professionals sharing medically accurate information with their patients in the exam room. This rule change amounts to a serious and unethical intrusion into the relationship between patients and their healthcare providers. Medicines360 calls on the administration to restore the ability of Title X providers to discuss medically accurate and comprehensive health information. As reported by the American College of Obstetricians and Gynecologists (ACOG), this rule undermines expert opinion and evidence-based practices and harms the health of women.


Share This